Selecting the right formulation pathway is crucial to ensuring the success of a pharmaceutical compound from early-stage development through to clinical trials. Under our Pharmorphix brand, Veranova offers an Enabling Formulation service designed to maximize the probability of success by providing data-driven insights that inform formulation decisions from the earliest stages.
In this white paper, Veranova’s Associate Director, Pharmorphix® Solid Form & Particle Engineering, Olana Couzins, explores how Veranova’s integrated approach—from pre-candidate selection to advanced development strategies—enables the identification of optimal drug formulations, enhances bioavailability, and
accelerates timelines.
